Theravance Biopharma

TBPH • NASDAQ •
Overview Stats Financials News

Yahoo Finance • 8 months ago

12 High Growth Value Stocks to Buy According to Seth Klarman

In this article, we will take a look at the 12 high growth value stocks to buy according to Seth Klarman. To see more such companies, go directly to 5 High Growth Value Stocks to Buy According to Seth Klarman. Following clear signals from... Full story

Yahoo Finance • a year ago

Theravance Biopharma to Participate in an Upcoming Investor Conference

DUBLIN, April 10, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will present at the 22nd Annual Needham Virtual Healthcare Conference on Monday, April 17 at 3:45 pm ET (12:45 pm PT/8:45 pm IST). Theravance Biopharma Logo (... Full story

Yahoo Finance • a year ago

Top Healthcare Stocks for March 2023

Top healthcare stocks include Theravance Biopharma for best value, Signify Health for fastest growth, and TransMedics Group for most momentum. Continue reading... Full story

Yahoo Finance • a year ago

Irenic Sends Letter to Theravance Biopharma Regarding the Urgent Need for a Governance Overhaul, Capital Return and Strategic Review

Despite Months of Private Engagement From Irenic and Presumably Other Investors, Chairman & CEO Rick E. Winningham and Theravance’s Board Refuse to Act in Shareholders’ Best Interests Notes Theravance’s Total Shareholder Returns are -50%... Full story

Yahoo Finance • a year ago

Theravance Biopharma, Inc. Highlights 2022 Accomplishments and 2023 Key Targets

Strategic priorities focused on continued Net Sales growth for YUPELRI® (revefenacin) and conduct of the ampreloxetine Phase 3 study (CYPRESS) in Multiple System Atrophy (MSA) patients with symptomatic neurogenic orthostatic hypotension (n... Full story

Yahoo Finance • 2 years ago

Theravance Biopharma to Report Third Quarter 2022 Financial Results on November 7, 2022

DUBLIN, Oct. 31, 2022 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its third quarter 2022 financial results and provide a business update after market close on Monday, November 7, 2022. An accompanying conference c... Full story

Yahoo Finance • 2 years ago

Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million

Further diversifies Royalty Pharma’s portfolio with market-leading respiratory therapy Expected to significantly add to long-term Adjusted Cash Receipts growth(1) (non-GAAP) NEW YORK, July 13, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc... Full story

Yahoo Finance • 2 years ago

Certara Appoints Eran Broshy as New Independent Board Member

PRINCETON, N.J., July 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Eran Broshy to its Board of Directors, effective July 11, 2022. His appointment brings... Full story

Yahoo Finance • 2 years ago

NICE and Deutsche Telekom Global Business Announce Comprehensive Partnership to Bring the Power of CXone to Enterprises Across Europe

The alliance enables companies across the continent to deliver frictionless, digital self-service and agent-assisted experiences with CXone HOBOKEN, N.J., April 13, 2022--(BUSINESS WIRE)--NICE (Nasdaq: NICE) today announced a partnership... Full story

Yahoo Finance • 2 years ago

NICE Actimize Positioned as Highest-Scoring Vendor Across Technology Excellence Metrics in 2022 Quadrant Knowledge Anti-Money Laundering Report

Using AI and Machine Learning, NICE Actimize’s solution optimizes detection models and uses predictive analytics to identify and prioritize suspicious alerts HOBOKEN, N.J., April 12, 2022--(BUSINESS WIRE)--NICE Actimize, a NICE (NASDAQ: N... Full story